Antimicrobial Resistance Awareness Week 2023: Antibiotic use over a long period of time is linked with increased risk of heart attack or stroke in women. A study, conducted in about 36,500 women, found that women in their late adulthood (age 60 and above) who consumed antibiotics for two months or more had the greatest risk […]
Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinsonâs. Its drug candidates include NTCELL for Parkinsonâs disease and the AI-116 combination drug candidate for dementia. […]
About The Study: Longer cumulative duration of attention-deficit/hyperactivity disorder (ADHD) medication use was associated with an increased risk of cardiovascular disease, particularly hypertension and arterial disease, compared with nonuse in this study of 278,000 individuals in Sweden ages 6 to 64 who had an incident ADHD diagnosis or ADHD medication dispensation. These findings highlight the importance […]
Algorae Pharmaceuticals (ASX: 1AI) is featuring in another high-profile collaboration with its plans to develop a range of novel treatments for medical conditions with unmet medical needs. The company, which recently entered into partnerships with the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and University of New South Wales (UNSW) to help investigate some of its […]
Search results A total of 295 articles were identified, mainly in the three electronic databases and only 3 additional records were manually found. Moreover, 93 duplicate articles were removed, and the remaining 202 were screened according to the inclusion criteria. After a review of the title and abstracts, 20 articles were included for the full-text […]
Cardiovascular disease is a serious threat to human life and health. Reasonable prevention and drug treatment are the cornerstones of tackling cardiovascular disease. Cardiovascular APIs are main components of drugs used to treat diseases of the cardiovascular system, including lipid-lowering drugs, anti-heart failure drugs, anti-arrhythmic drugs, anti-hypertensive drugs, anti-anginal drugs and other chemical drugs. Antihypertensive Series […]
Abstract Weather conditions influence the incidence of cardiovascular disease. However, few studies have investigated the association between weather temperature and humidity and cerebrovascular disease hospitalizations in a super-aging society. We included 606,807 consecutive patients with cerebrovascular disease admitted to Japanese acute-care hospitals between 2015 and 2019. The primary outcome was the number of cerebrovascular disease […]
Bayer has ended a clinical trial for its new atrial fibrillation (AFib) drug much earlier than planned based on recommendations from the Independent Data Monitoring Committee (IDMC). OCEANIC-AF is a phase III study comparing Bayer’s oral factor XIa inhibitor, asundexian, with the oral anticoagulant (OAC) apixaban in AFib patients facing a high stroke risk. The […]
The long-term use of attention-deficit/hyperactivity disorder (ADHD) medications may increase a person’s risk of significant cardiovascular issues, according to a new analysis published in JAMA Psychiatry.[1] “The use of ADHD medication has increased greatly in both children and adults during the past decades,” wrote first author Le Zhang, PhD, with the department of medical epidemiology […]
Researchers Uncover Decline in Cardiovascular Health Among Middle-Aged Adults and Persistent Income-Based Inequities BOSTON – Public health experts credit steady declines in cardiovascular health in the second half of the 20th century to medical advances and improvements in important risk factors. However, data from the Centers for Disease Control and Prevention point to a stagnation […]